Apotex Health (TSX:APTX) reported quarterly earnings of $0.70 per share which beat the analyst consensus estimate of $0.51 by 37.25 percent. This is a 22.22 percent decrease over earnings of $0.90 per share from the same period last year. The company reported quarterly sales of $848.000 million which beat the analyst consensus estimate of $840.780 million by 0.86 percent. This is a 25.74 percent decrease over sales of $1.142 billion the same period last year.